DICOT Stock Chart & Stats
kr0.19
<kr0.01(4.47%)
At close: 4:00 PM EDT
kr0.19
<kr0.01(4.47%)
Day’s Range― - ―
52-Week Rangekr0.18 - kr1.05
Previous CloseN/A
Volume14.90M
Average Volume (3M)11.63M
Market Cap
kr628.53M
Enterprise Valuekr812.84
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.06
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding3,468,689,200
10 Day Avg. Volume10,898,606
30 Day Avg. Volume11,629,260
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DICOT FAQ
What was Dicot Pharma AB’s price range in the past 12 months?
Dicot Pharma AB lowest stock price was kr0.17 and its highest was kr1.05 in the past 12 months.
What is Dicot Pharma AB’s market cap?
Dicot Pharma AB’s market cap is kr628.53M.
When is Dicot Pharma AB’s upcoming earnings report date?
Dicot Pharma AB’s upcoming earnings report date is Aug 20, 2026 which is in 17 days.
How were Dicot Pharma AB’s earnings last quarter?
Dicot Pharma AB released its earnings results on Apr 30, 2026. The company reported -kr0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.007.
Is Dicot Pharma AB overvalued?
According to Wall Street analysts Dicot Pharma AB’s price is currently Overvalued.
Does Dicot Pharma AB pay dividends?
Dicot Pharma AB does not currently pay dividends.
What is Dicot Pharma AB’s EPS estimate?
Dicot Pharma AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dicot Pharma AB have?
Dicot Pharma AB has 3,468,689,200 shares outstanding.
What happened to Dicot Pharma AB’s price movement after its last earnings report?
Dicot Pharma AB reported an EPS of -kr0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.502%.
Which hedge fund is a major shareholder of Dicot Pharma AB?
Currently, no hedge funds are holding shares in SE:DICOT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
SynAct Pharma AB
―
Saniona AB
―
C-Rad AB Class B
―
Xspray Pharma AB
―
Sedana Medical AB
―